Keyphrases
Type 2 Diabetes Mellitus (T2DM)
87%
Statins
71%
Diabetes
67%
Tayside
62%
Statin Intolerance
59%
Genome-wide Association Study
55%
Meta-analysis
49%
Scotland
48%
Angiotensin-converting Enzyme Inhibitor (ACEi)
43%
Scottish
41%
Missense Variants
37%
Rare Variants
37%
Cardiovascular Outcomes
36%
Asian Indians
35%
Chronic Kidney Disease
34%
Intolerance
34%
Lipoprotein-associated Phospholipase A2 (Lp-PLA2)
34%
LILRB5
34%
Confidence Interval
32%
Genetic Variants
32%
Diabetes Genetics
32%
SLCO1B1
30%
Thyroid Hormones
26%
Adverse Drug Reaction
26%
Clinical Trials
26%
Common Variants
25%
Angiotensin Receptor Blockers
25%
Sulfonylurea
25%
Genotype
24%
Creatine Kinase
24%
Diabetic Retinopathy
24%
Single nucleotide Polymorphism
22%
Observational Cohort Study
22%
Young-onset Diabetes
22%
Pharmacogenomics
22%
β-cell Function
22%
Angioedema
22%
ACE Inhibitors
22%
Hemoglobin A1c (HbA1c)
21%
White European
21%
Myalgia
20%
Statin-induced Myopathy
20%
Odds Ratio
20%
Diabetes Management
19%
Major Adverse Cardiovascular Events
18%
Atrial Fibrillation
18%
Cardiovascular Mortality
18%
Patients with Diabetes
17%
Electronic Medical Records
17%
Insulin Resistance
17%
Biochemistry, Genetics and Molecular Biology
Statin
78%
Genetics
72%
Genome-Wide Association Study
69%
Angiotensin-Converting Enzyme
44%
Enzyme Inhibitor
44%
Missense
36%
Allele
36%
Genetic Divergence
30%
Genotyping
29%
Angiotensin Receptor
25%
Polygenic Score
25%
Rare Variant
24%
Exome Sequencing
24%
Sulfonylurea
23%
Cell Function
22%
Angioedema
22%
Lipoprotein-Associated Phospholipase A2
22%
Pharmacogenomics
22%
Thyrotropin Blood Level
22%
Single-Nucleotide Polymorphism
21%
SLCO1B1
21%
Electronic Medical Record
20%
Creatine Kinase
17%
HDL-Cholesterol
17%
Glycated Hemoglobin
17%
Drug Response
16%
Genomics
16%
Genetic Determinism
14%
Clinical Trial
14%
ABC Transporter
13%
ATP-binding Cassette Transporter
13%
Thyroid Hormone
13%
C-Peptide
12%
Leukocyte Immunoglobulin-Like Receptors
12%
Genetic Screening
11%
Epidemiological Data
11%
Waist Circumference
11%
Electronic Health Record
11%
Cluster Analysis
11%
Triacylglycerol Blood Level
11%
Body Mass
11%
Thyroid Function
11%
Lipoprotein
11%
Phospholipase A
11%
Observational Study
11%
Comparison Trial
11%
PDE10A
11%
Familial Hypercholesterolemia
11%
Genetic Architecture
11%
Insulin Resistance
11%
Medicine and Dentistry
Diabetes
100%
Maturity Onset Diabetes of the Young
61%
Cardiovascular System
36%
Chronic Kidney Disease
34%
Asian Indians
34%
Allele
25%
Body Mass Index
23%
Beta Cell
22%
Cell Function
22%
Cohort Study
22%
ACE Inhibitor
22%
Angioedema
22%
Systematic Review
22%
Angiotensin Receptor Antagonist
21%
Statin
20%
Cardiovascular Disease
20%
Sulfonylurea
18%
Genome Wide Association Study
16%
Nephropathy
14%
Prevalence
13%
Meta-Analysis
13%
Gene Linkage
13%
Exome Sequencing
12%
Cluster Analysis
11%
Acute Renal Failure
11%
Kidney Graft
11%
Comparison Trial
11%
Impaired Glucose Tolerance
11%
COVID-19
11%
Patient with Type 2 Diabetes
11%
Genetic Screening
11%
Renal Failure
11%
Renal Replacement Therapy
11%
Diabetic Nephropathy
11%
Angiotensin Receptor
11%
Homeostatic Model Assessment
11%
Familial Hypercholesterolemia
11%
Substitution Therapy
11%
Rural Population
11%
Thyrotropin
11%
Malignant Neoplasm
11%
Creatine Kinase
11%
Liver Disease
11%
Glycemic
11%
Radiology
11%
Computed Tomography Studies
11%
Amyloid Protein
11%
Muscle Disease
11%
Fragility Fracture
11%
Clinical Trial
11%